Quantcast

Posts related to ‘Puricase’

Savient’s New Gout Treatment Hits Targets (SVNT)

Savient Pharmaceuticals Inc. (NASDAQ: SVNT) is seeing its shares surging in pre-market trading.  The company showed statistically significant positive results for the Puricase Phase III study in treatment-failure of gout ...
Read Full Story »